EUVIMEDEUVIMED entdecken
Crossref

Deep learning-driven discovery and optimization of natural LSD1 inhibitors for the treatment of Alzheimer's disease

Zhonghua Li, Tiancheng Sun, Mengyu Han, Bingyu Xiao, Sijia Liu, Jiaxin Zhang, JinLian Ma, Huifen Ma, Jige Yang, Zhenqiang Zhang

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.110396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Zhonghua Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Chinese Medical Sciences; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao; Henan Univers…. Hauptthemen laut MEDLINE: Alzheimer Disease, Histone Demethylases, Enzyme Inhibitors, Neuroprotective Agents. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Science and Technology Innovation Talents in Universities of Henan Province, Henan Province Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a prevalent neurodegenerative disorder with limited effective disease-modifying treatments. Lysine-specific demethylase 1 (LSD1) has emerged as a promising target for AD therapy. However, current LSD1 inhibitors for AD still suffer from poor brain permeability, off-target toxicity, and chemical-scaffold scarcity. Herein, we developed a multimodal deep learning model (PLM-CAFT-DTA) for drug-target affinity (DTA) prediction. This model integrates ChemBERTa, ESM-2, graph attention, and cross-attention fusion to achieve high prediction precision. Using this model combined with virtual screening and molecular simulation, we identified silybin as a hit compound from a library of over 70,000 natural products. After rational modification, compound S3 was obtained with significantly improved LSD1 inhibition (IC₅₀ = 2.30 μM), approximately 7-fold more potent than the silybin. In vitro assays showed that S3 exhibited favorable neuroprotective and antioxidant activities. In APP/PS1 mice, S3 upregulated hippocampal H3K9me2, suppressed neuroinflammation and Aβ deposition, and improved cognitive function. By addressing unmet demands for AI-assisted anti-AD lead discovery, this study provides a generalized DTA tool for early-stage drug development, and identifies S3 as a novel LSD1 inhibitor with potent anti-AD efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHistone DemethylasesEnzyme InhibitorsNeuroprotective AgentsDrug DiscoveryDeep LearningBiological ProductsAnimalsHumansMiceStructure-Activity RelationshipMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

Alzheimer's diseaseAmyloid βDeep learningLSD1 inhibitorNeuroinflammationVirtual screening

Substanzen

Histone DemethylasesEnzyme InhibitorsKDM1A protein, humanNeuroprotective AgentsBiological Products

Autor:innen und Institutionen

  • Academy of Chinese Medical Sciences; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao; Henan University of Chinese Medicine, Zhengzhou 450046, China. Electronic address:…
  • Academy of Chinese Medical Sciences; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao; Henan University of Chinese Medicine, Zhengzhou 450046, China.

Förderung

  • Science and Technology Innovation Talents in Universities of Henan Province
  • Henan Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Li, Z., Sun, T., Han, M., Xiao, B., Liu, S., Zhang, J., Ma, J., Ma, H., Yang, J., & Zhang, Z. (2026). Deep learning-driven discovery and optimization of natural LSD1 inhibitors for the treatment of Alzheimer's disease. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110396

Vancouver

Li Z, Sun T, Han M, Xiao B, Liu S, Zhang J, et al. Deep learning-driven discovery and optimization of natural LSD1 inhibitors for the treatment of Alzheimer's disease. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110396

BibTeX
@article{Li2026,
  author = {Li, Zhonghua and Sun, Tiancheng and Han, Mengyu and Xiao, Bingyu and Liu, Sijia and Zhang, Jiaxin and Ma, JinLian and Ma, Huifen and Yang, Jige and Zhang, Zhenqiang},
  title = {Deep learning-driven discovery and optimization of natural LSD1 inhibitors for the treatment of Alzheimer's disease},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.110396}
}
Kostenlos starten →